Virtune Rebalances Crypto Altcoin Index ETP as Scheduled for May 2026
Virtune AB announced the monthly rebalancing of its Virtune Crypto Altcoin Index ETP on June 2, 2026. The exchange-traded product is listed on Nasdaq Stockholm, Nasdaq Helsinki, and Xetra.
techjuice.pkVirtune AB (Publ) completed the monthly rebalancing of the Virtune Crypto Altcoin Index ETP for May 2026, the company said from Stockholm on June 2. The product carries ISIN code SE0023260716 and trades on Nasdaq Stockholm, Nasdaq Helsinki, and Xetra. 34 percent.
The company also offers the Virtune Bitcoin ETP, Virtune Staked Ethereum ETP, Virtune Stellar ETP, Virtune Staked Solana ETP, Virtune Staked Polkadot ETP, Virtune XRP ETP, Virtune Avalanche ETP, Virtune Litecoin ETP, Virtune Chainlink ETP, Virtune Arbitrum ETP, Virtune Polygon ETP, Virtune Staked Cardano ETP, Virtune Crypto Top 10 Index ETP SEK, Virtune Crypto Top 10 Index ETP EUR, Virtune Bitcoin Prime ETP, Virtune Coinbase 50 Index ETP, Virtune Staked Near ETP, Virtune Sui ETP, Virtune Stablecoin Index ETP, Virtune Bittensor ETP, Virtune BNB ETP, and Virtune Hyperliquid ETP.
Transparency
Reported by a single outlet. This score reflects source tier and factual specificity — corroboration is limited with one source.
Story details
Related Stories
thehindu.comU.S. Strikes Botswana-Flagged Tanker in International Waters; Iran Blockade in Effect
A U.S. aircraft fired an AGM-114 Hellfire missile into the engine room of the M/T Lexie on Tuesday, disabling the unladen vessel as it headed toward Kharg Island. The strike followed repeated ignored warnings over 24 hours.
prnewswire.comFed Chairman Names Two Outside Advisers During Transition
Federal Reserve Chairman Kevin Warsh appointed two interim advisers shortly after taking the post. One previously contributed to a conservative plan calling for major changes at the central bank.
insidermonkey.comForte Biosciences Accepts Resignation of Director David Veitch
Forte Biosciences disclosed the resignation of independent director David Veitch from its board effective June 1 2026. The departure reduces the company's board size and triggers standard SEC and Nasdaq disclosure obligations for director changes at the clinical-stage biopharmace…